Company announcements


Dealing in securities by directors and prescribed officers: vesting of shares and settlement by on market sales and equity settlement

Johannesburg, Wednesday, 1 November 2023. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following dealings in securities by directors and prescribed officers of Harmony in relation to the vesting and settlement of deferred share awards made pursuant to the provisions of the Harmony Deferred Share Plan 2018 are disclosed:

 1.  Name of director:PW Steenkamp (Chief Executive Officer)
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:149 270
 Number of ordinary shares locked up towards minimum shareholding requirement:54 397
 Number of vested shares sold on market:94 873
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R8,546 141
 Number of shares retained in own name:0
   
 Nature and extent of prescribed officer’s interest:Direct beneficial
 2.  Name of director: BP Lekubo (Financial Director)
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:  56 331
 Number of ordinary shares locked up towards minimum shareholding requirement:28 165
 Number of vested shares sold on market:28 166
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R2,537 188
 Number of shares retained in own name:0
   
 Nature and extent of prescribed officer’s interest:Direct beneficial
 3.  Name of director: HE Mashego (Executive Director)
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:50 578
 Number of ordinary shares locked up towards minimum shareholding requirement:25 288
 Number of vested shares sold on market:12 000
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R1,080 958 
 Number of shares retained in own name:13 290
 Total value of shares retained in own name at R90.60:R1,204 074
 Nature and extent of prescribed officer’s interest:Direct beneficial
 4.  Name of prescribed officer: B Nel
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:51 025
 Number of ordinary shares locked up towards minimum shareholding requirement:  25 511
 Number of vested shares sold on market:25 514
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R2,298 296
 Number of shares retained in own name:0
   
 Nature and extent of prescribed officer’s interest:Direct beneficial
 5.  Name of prescribed officer:  M van der Walt
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:40 659
 Number of ordinary shares locked up towards minimum shareholding requirement:16 060
 Number of vested shares sold on market:11 437
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R1,030 243
 Number of shares retained in own name:13 162
 Total value of shares retained in own name at R90.60:R1,192 477
 Nature and extent of prescribed officer’s interest:Direct beneficial
 6.  Name of prescribed officer:  J van Heerden
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:63 513
 Number of ordinary shares locked up towards minimum shareholding requirement:31 755
 Number of vested shares sold on market:31 758
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R2,860 754
 Number of shares retained in own name:0
   
 Nature and extent of prescribed officer’s interest:Direct beneficial
 7.  Name of prescribed officer:  A Buthelezi
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:39 083
 Number of ordinary shares locked up towards minimum shareholding requirement:  6 246
 Number of vested shares sold on market:25 693
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R2,314 420
 Number of shares retained in own name:7 144
 Total value of shares retained in own name at R90.60:R647 246
 Nature and extent of prescribed officer’s interest:Direct beneficial
 8.  Name of prescribed officer:  M Naidoo-Vermaak
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:42 060
 Number of ordinary shares locked up towards minimum shareholding requirement:  6 765
 Number of vested shares sold on market:35 295
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R3,179 367
 Number of shares retained in own name:0
   
 Nature and extent of prescribed officer’s interest:Direct beneficial
 9.  Name of company secretary:  SS Mohatla
 Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018
 Vesting Date:18 September 2023
 Class of securities:Ordinary shares
   
 Number of ordinary shares vested:18 610
 Number of vested shares sold on market:18 610
 Date of bulk on-market sale of shares:26 October 2023
 On-market sale price per share:Volume weighted average price of R90.0798 per share (with a low of R87.36 per share and a high of R92.20 per share)
 Total value of shares sold on market prior to deduction of tax liability:R1,676 385
 Number of shares retained in own name:0
   
 Nature and extent of prescribed officer’s interest:Direct beneficial

Prior clearance was obtained in respect of the above dealings in securities in compliance with paragraph 3.66 of the JSE Listings Requirements.

Ends.

For more details contact:

Jared Coetzer
Head of Investor Relations
+27 (0) 82 746 4120

Johannesburg, South Africa
1 November 2023

Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited